Jyong Biotech Ltd. filed for an IPO that could raise as much as $40 million to advance a pipeline that includes several prospects for urinary system disorders, including one that has reached the NDA ...

AIE is a unique photophysical phenomenon, and its distinctive luminescence properties have demonstrated significant potential in the biomedical field. In urinary system diseases, AIE materials, with ...

Uncomplicated urinary tract infections carry major quality of life burden as recurrence and resistance complicate therapy selection.

Jyong Biotech Ltd., a Taiwan-based biotechnology company focused on developing innovative plant-derived drugs for urinary system diseases, announced the closing of its initial public offering (IPO) on ...

Urinary tract infections (UTIs) are a common health issue that affects a vast majority of the Indian population. According to the European Journal of Pharmaceutical and Medical Research, UTIs are most ...